Skip to main content

NIA Funding Line Policy for FY 2020

NIH is currently operating under the “Continuing Appropriations Act, 2020 and Health Extenders Act of 2019”. (CR) The act covers operations through November 21, 2019 at 99.3209 percent of the FY 2019 enacted level. During this CR NIH will issue non-competing awards at a level below that indicated on the most recent Notice of Award (generally up to 90% of the previously committed level). NIA is providing interim guidance on funding line policy for competing awards during this continuing resolution. Full details of the funding line policy will become available later in the year under a longer-term resolution or a full year budget.

NIA Competing Award Funding Policy during the CR

CSR-reviewed Research Applications
  General pay line, <500k General pay line, => $500k ADRD pay line, < 500k ADRD pay line, => 500k
All (except below)
9%
6%
28%
25%
New investigator R01s
12%
9%
31%
28%
Early Stage Investigator R01s
14%
11%
33%
30%

 

NIA-reviewed Research Applications
  General pay line ADRD pay line
Program projects
15
40
Other NIA-reviewed research
15
40

NIA Competing Award Funding Policy

General Allocation: NIA is administratively reducing competing awards in FY 2020 by an average of 18% within the general allocation. NIA may reduce the size of the administrative cut later in the fiscal year. The average cut policy applies to all research project awards except R03s (small grants), R21s (exploratory/developmental awards), and R15s (Academic Enhancement Research Awards). These awards (R03, R21, R15) generally receive the study-section recommended amount of support. The 18% cut on remaining awards is an average. Individual awards may be reduced by more or less than that percentage.

Alzheimer's Allocation (AD/ADRD pay line): NIA is awarding the study-section recommended amount of support for applications within the Alzheimer's allocation but with adjustments as deemed appropriate by staff.

Though NIA expects to pay most applications within these lines, when scientific concerns are identified in peer review that are sufficient to weaken the case for making an award we may alternatively provide short term support (R56) or invite a re-submission of the application. Similarly, we may pay a few applications beyond the pay lines when they focus on high priorities of the Institute.

Applications Responding to Alzheimer’s-related program announcements

FOAs: PAR19-070, PAR19-071.

            PAR18-497, PAR18-516, PAR18-519, PAR 18-581, PAR18-582, PAR18-760

            PAR17-031, PAR17-032, PAR17-033, PAR17-039, PAR17-054

We are paying applications responding to the above PARs by impact rating rank order rather than by percentile rank. We are paying these applications to an impact rating of 40. New Investigator applications are paid to a score of 43 and early stage investigator applications are paid to a score of 45. Though these pay lines are generally followed, NIA may pay a few applications beyond these lines or choose to provide short-term support or require a resubmission from a few applications within these lines, following both peer review comments and published funding priority guidelines.

Career Award Pay Lines (Impact Ratings)

General Allocation: 18
Alzheimer's Allocation: 28

NIA may pay a few applications beyond these lines or require a resubmission from a few applications within these lines, following both peer review comments and published funding priorities.